-
Gefitinib, sold
under the
brand name Iressa, is a
medication used for
certain breast, lung and
other cancers.
Gefitinib is an EGFR inhibitor, like erlotinib...
- the U.S. Food and Drug
Administration (FDA)
approved the
quinazoline gefitinib. The drug,
produced by AstraZeneca, is an
inhibitor of the
protein kinase...
- this case,
Gefitinib is the
inhibitor of
tyrosine kinase.
Incorrect tyrosine kinase function can lead to non-small cell lung cancer.
Gefitinib is a tyrosine...
-
therapeutics directed against EGFR (called "EGFR inhibitors", EGFRi),
including gefitinib, erlotinib, afatinib,
brigatinib and
icotinib for lung cancer, and cetuximab...
-
Methylphenidate and dextroamphetamine-induced
peripheral vasculopathy Gefitinib Obstruction of capillaries:
Cryoglobulinaemia –
proteins in the blood...
- in the
preparation of the
antibiotic linezolid, the
anticancer agent gefitinib (brand name Iressa) and the
analgesic dextromoramide. In
research and...
- are alternatives,
including quality-****ured
biosimilars Afatinib and
gefitinib are
alternatives Pembrolizumab is an alternative,
including quality-****ured...
-
Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
- for
bronchorrhea vary
depending on the
inciting cause; they include:
gefitinib -
epidermal growth factor receptor tyrosine kinase inhibitor indomethacin...
- the
frequency and
amplitude modulated, they
applied the EGFR
inhibitor gefitinib or the
highly selective MAPK/ERK
kinase (MEK)
inhibitor PD0325901 (PD)...
